Back to Search
DANIEL TU, M.D., PH.D.
M.D., PH.D.
Ophthalmology Physician
NPI: 1467610311IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
036.130354(IL)MD158027(OR)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
Class of 2008
Research & Publications (20)
Structure and function of the yeast U-box-containing ubiquitin ligase Ufd2p.
PMID 17890322·Proc Natl Acad Sci U S A·2007
7-preclinical
Detection of viable autotransplanted splenic tissue by Tc-99m sulfur colloid.
PMID 17495744·J Trauma·2007
5-case
[Resistance and efficacy of treatment in relapse pulmonary tuberculosis].
PMID 11225030·Zhonghua Jie He He Hu Xi Za Zhi·2000
8-other
A randomized placebo-controlled study of tamoxifen after adjuvant chemotherapy in premenopausal women with early breast cancer (National Cancer Institute of Canada--Clinical Trials Group Trial, MA.12).
PMID 19628570·Ann Oncol·2010
2-rct
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.
PMID 19273701·J Clin Oncol·2009
2-rct
The identification of a tumor of the cervix on PET/CT with bladder filling and emptying.
PMID 19387208·Clin Nucl Med·2009
5-case
Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2.
PMID 19223579·Proc Natl Acad Sci U S A·2009
8-other
A randomized, double-blind, controlled trial of perioperative administration of gabapentin, meloxicam and their combination for spontaneous and movement-evoked pain after ambulatory laparoscopic cholecystectomy.
PMID 19151299·Anesth Analg·2009
2-rct
Prospective cost-effectiveness analysis of cetuximab in metastatic colorectal cancer: evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 trial.
PMID 19666851·J Natl Cancer Inst·2009
8-other
Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.
PMID 19401546·J Natl Cancer Inst·2009
8-other
Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis.
PMID 19070891·Lancet·2009
1-meta
Stopping a trial early in oncology: for patients or for industry?
PMID 19150952·Ann Oncol·2009
8-other
Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
PMID 18986330·Clin Exp Pharmacol Physiol·2009
7-preclinical
Comparison of toxicity associated with early morning versus late afternoon radiotherapy in patients with head-and-neck cancer: a prospective randomized trial of the National Cancer Institute of Canada Clinical Trials Group (HN3).
PMID 18805649·Int J Radiat Oncol Biol Phys·2009
4-observational
[Analysis and analyzing mechanisms of HERG channel kinetics].
PMID 19024448·Sheng Wu Yi Xue Gong Cheng Xue Za Zhi·2008
7-preclinical
K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
PMID 18946061·N Engl J Med·2008
3-trial
High extracellular potassium ion concentration attenuates the blockade action of ketanserin on Kv1.3 channels expressed in xenopus oocytes.
PMID 19187600·Chin Med J (Engl)·2008
7-preclinical
The Colon Health and Life-Long Exercise Change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group.
PMID 19079628·Curr Oncol·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3375 SW TERWILLIGER BLVD, MAIL CODE, CEI MARQUAM HILL
PORTLAND, OR 97239 - Phone
- (503) 494-3394
Quick Facts
- NPI
- 1467610311
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile